The 35 new pQTLs overlap with several loci of biomedical relevance, including a trans-pQTL for ANGPTL6 at the COLEC11 locus associated with low-density lipoprotein (LDL)-cholesterol levels, a trans-pQTL for BRE (brain and reproductive organ expressed (TNFRSF1A modulator)) at the CFH locus associated with age-related macular degeneration and immunoglobulin (Ig)A nephropathy, a cis-pQTL for galactosylceramidase associated with inflammatory bowel disease and many others that can now be considered as candidate drug targets for these diseases. The gene discussed is ANGPTL6; the disease is kidney disorder.